News | February 24, 2009

Researchers Work on PET with IMRT for "Dose Painting"

February 24, 2009 - Researchers are testing the use of positron emission tomography (PET) for dose painting, but have found the technique is limited by PET’s spatial resolution, according to researchers from the Catholic University of Louvain, Brussels, Belgium (Radiother. Oncol. doi: 10.1016/j.radonc.2008.11.014).

The theory is to use PET with a radiotherapy plan that takes account of tumor physiology, and to use PET to "paint" the dose to regions of intense activity or radiation resistance. PET is used in combination with intensity-modulated radiotherapy (IMRT) with an appropriate functional imaging modality.

The use of PET for dose painting relies on a perfect correlation between the observed PET signal and the underlying biology of interest. To test this, Nicolas Christian and colleagues imaged 15 tumor-bearing mice with PET following injection of the radiotracer 2-fluoro-2-deoxyglucose (18F-FDG). The mice were also imaged with MRI and then assessed using autoradiography.

The PET and autoradiography images however did not always match, particularly in tumor sub-volumes with high 18F-FDG-activity. This mismatch is significant because a biological image-guided IMRT plan would most likely increase the dose to these sites. The larger the tumor volume and the lower the activity threshold, then the better the match.

"Unfortunately, we do not yet have access to spatial image resolution that is good enough to be able to visualize what is going on at the microscopic level. We may make fairly large mistakes in the dose distribution by relying on what we see on the PET," said Vincent Grégoire, professor in radiation oncology at the Catholic University of Louvain and corresponding author for the paper.

Grégoire noted that if a PET system with a higher resolution were developed, the technique may be viable. The researchers are instead examining whether alternative radioisotope tracers could provide a better way of finding specific sites in the tumor where the dose should be increased, such as clusters of hypoxic cells. The researchers still want to investigate the concept of PET-based dose painting.

Source: Medical Physics Web

For more information: medicalphysicsweb.org

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
UZ Leuven Treats First European Patient on Varian Halcyon Cancer Treatment System
News | Intensity Modulated Radiation Therapy (IMRT) | October 25, 2017
Varian recently announced an 80-year-old male with head and neck cancer became the first patient in Europe to be...
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
Overlay Init